ResMed

RMD Health Care Market cap $32.2B as of Sep 14, 2026 16:00 ET S&P 500

Q4 FY26 Apr 1 – Jun 30, 2026 reported Aug 13, 2026

Revenue$1.46B +9% year over year

Gross profit$0.86B 59% margin

Operating profit$0.45B 31% margin

Net profit$0.38B 26% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q4 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	1.46	100%	+9%
Sleep & breathing health	1.26	86%
Residential care software	0.17	12%
Other revenue	0.03	2%
Cost of revenue	−0.60	41%
Gross profit	0.86	59% margin	−2pp
R&D	−0.11	7%	+1pp
SG&A	−0.30	20%	+0pp
Other	−0.01	1%	+0pp
Operating profit	0.45	31% margin	−3pp
Other income, net	0.03
Tax	−0.09
Net profit	0.38	26% margin	−2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	1.43	100%	+11%
Sleep & breathing health	1.26	88%	+11%
Residential care software	0.17	12%	+6%
Cost of revenue	−0.54	38%
Gross profit	0.89	62% margin	+3pp
R&D	−0.09	6%	+0pp
SG&A	−0.29	20%	+1pp
Other	−0.01	1%	+0pp
Operating profit	0.50	35% margin	+2pp
Tax	−0.10
Net profit	0.40	28% margin	+0pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.42	100%	+11%
Sleep & breathing health	1.26	88%	+12%
Residential care software	0.17	12%	+7%
Cost of revenue	−0.54	38%
Gross profit	0.88	62% margin	+3pp
R&D	−0.09	6%	+0pp
SG&A	−0.28	20%	+1pp
Other	−0.02	1%	+0pp
Operating profit	0.49	35% margin	+2pp
Tax	−0.10
Net profit	0.39	28% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.34	100%	+9%
Sleep & breathing health	1.17	88%	+10%
Residential care software	0.17	12%	+6%
Cost of revenue	−0.52	39%
Gross profit	0.82	61% margin	+3pp
R&D	−0.09	7%	+0pp
SG&A	−0.26	19%	+0pp
Other	−0.03	2%	+0pp
Operating profit	0.45	33% margin	+2pp
Tax	−0.10
Net profit	0.35	26% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.35	100%	+10%
Sleep & breathing health	1.18	88%	+10%
Residential care software	0.17	12%	+10%
Cost of revenue	−0.53	39%
Gross profit	0.82	61% margin	+2pp
R&D	−0.09	6%	+0pp
SG&A	−0.27	20%	+0pp
Other	−0.01	1%	+0pp
Operating profit	0.46	34% margin	+3pp
Tax	−0.08
Net profit	0.38	28% margin	+4pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q4 FY26 Apr 1 – Jun 30, 2026 reported Aug 13, 2026 Operating margin 31% Net profit $0.38B	Apr 1 – Jun 30, 2026	Aug 13, 2026	$1.46B	+9%	31%	$0.38B	26%
Q3 FY26 Jan 1 – Mar 31, 2026 reported May 1, 2026 Operating margin 35% Net profit $0.40B	Jan 1 – Mar 31, 2026	May 1, 2026	$1.43B	+11%	35%	$0.40B	28%
Q2 FY26 Oct 1 – Dec 31, 2025 reported Jan 30, 2026 Operating margin 35% Net profit $0.39B	Oct 1 – Dec 31, 2025	Jan 30, 2026	$1.42B	+11%	35%	$0.39B	28%
Q1 FY26 Jul 1 – Sep 30, 2025 reported Oct 31, 2025 Operating margin 33% Net profit $0.35B	Jul 1 – Sep 30, 2025	Oct 31, 2025	$1.34B	+9%	33%	$0.35B	26%
Q4 FY25 Apr 1 – Jun 30, 2025 reported Aug 8, 2025 Operating margin 34% Net profit $0.38B	Apr 1 – Jun 30, 2025	Aug 8, 2025	$1.35B	+10%	34%	$0.38B	28%